ASCOMP WITH CODEINE CAPSULE

Butalbital, Aspirin, Caffeine and Codeine Phosphate
$1.1684per EA
DEA Schedule CIII

Strength

325; 50; 40; 30 mg/1; mg/1; mg/1; mg/1

NDC

51991007401

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA075231

On Market Since

5/1/2009

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Barbiturate
Barbiturates
Central Nervous System Stimulant
Central Nervous System Stimulation
Cyclooxygenase Inhibitors
Decreased Platelet Aggregation
Decreased Prostaglandin Production
Full Opioid Agonists
Methylxanthine
Nonsteroidal Anti-inflammatory Drug
Opioid Agonist
Platelet Aggregation Inhibitor
Xanthines

Price History

1W

0.0%

1M

+10.1%

3M

+14.6%

6M

+21.0%

1Y

+2.3%

3Y

-9.1%

5Y

+9.2%

All

+119.9%